Actions Panel
Cardiovascular Innovations 2023: The Operators Enclave
CVI 2023 is a world-class meeting focused on state-of-the-art therapy for peripheral, coronary, and structural heart disease.
When and where
Date and time
July 20 · 10am - July 22 · 2pm CDT
Location
JW Marriott Austin 110 East 2nd Street Austin, TX 78701
Refund Policy
About this event
- 2 days 4 hours
- Mobile eTicket
JULY 20-22, 2023
JW Marriott Downtown Austin, TX
Cardiovascular Innovations 2023: The Operators Enclave(TM) is a world-class meeting focused on state-of-the-art therapy for peripheral, coronary, and structural heart disease. The conference features:
- Highly interactive expert discussions focused on professional experiences
- An emphasis on the latest innovations in interventional cardiovascular care
- Live case transmissions by the world's leading operators in the United States and Europe
- Satellite symposia and hands-on workshops
TARGET AUDIENCE
Cardiovascular Innovations 2023: The Operators Enclave(TM) is designed to meet the needs of cardiologists, surgeons, internists, trainees, investigators, nurses, nurse practitioners, physician assistants and allied health care staff who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases. The focus of the conference is on innovative health care solutions for these patients.
ABOUT CARDIOVASCULAR INNOVATIONS FOUNDATION
Cardiovascular disease is the number one cause of death globally, accounting for nearly 17.5 million deaths each year. Cardiovascular disease may strike those in their prime years and, due to population aging, also afflict elderly people who are otherwise living healthy lives. Improvements in cardiovascular therapy have markedly reduced procedural risk, and thereby enabled the treatment of a broad range of patients, more than ever before in the history of medicine. Nonetheless, significant disparities in the delivery of cardiovascular care continue to exist, leading to large unmet clinical needs for many patients worldwide. Innovation in the delivery of cardiovascular care, as well as education of the public at-large, is essential for optimizing the management of these patients.
The Cardiovascular Innovations Foundation is organized and operated exclusively for charitable, scientific, and educational purposes within the meaning of Section 501(c)(3) of the Internal Revenue Code.
The mission of the Foundation is to address unmet needs in cardiovascular care through the study, design, and development of innovative health care solutions and education of health care providers and the larger public.
BOARD OF DIRECTORS
Subhash Banerjee, MD, FACC, FSCAI
Baylor Heart and Vascular Hospital, Dallas, TX
Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FSCAI, FESC
Minneapolis Heart Institute at Abbott Northwestern Hospital
Mehdi H. Shishehbor, DO, MPH, PhD, FACC, FAHA, FSCAI
University Hospitals of Cleveland
Paul Sorajja, MD, FACC, FAHA, FSCAI
Minneapolis Heart Institute at Abbott Northwestern Hospital